首页> 外文OA文献 >IN VITRO FERTILITY TEST OF HUMAN SPERMATOZOA MEMBRANE PROTEIN FERTILIN BETA ANTIBODY IN MICE (Mus musculus Balb/c) AS IMMUNOCONTRACEPTIVE CANDIDATE
【2h】

IN VITRO FERTILITY TEST OF HUMAN SPERMATOZOA MEMBRANE PROTEIN FERTILIN BETA ANTIBODY IN MICE (Mus musculus Balb/c) AS IMMUNOCONTRACEPTIVE CANDIDATE

机译:小鼠(Mus Musculus Balb / c)中人精子膜蛋白培养蛋白β抗体的体外生育率试验作为免疫电池候选者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One of the materials as potential candidates immunocontraception material is spermatozoa. Fertilin beta is spermatozoa membrane protein and is found only in mature spermatozoa and ejaculate, which serves as an adhesion molecule. Spermatozoa membrane protein that is used as an ingredient immunocontraception candidate, must have specific criteria that the specificity of spermatozoa, the role of antigen in the fertilization process, which includes the formation of immunogenicity sufficient antibody response has the potential to block fertilization. Antibodies against spermatozoa affect the stages before fertilization of the reproductive process and can hinder the development of the embryo after fertilization. Until now very little research data spermatozoa membrane protein as an ingredient immunocontraception are up to the test of experimental animals. The research objective is to prove the role of the resulting antibody induction of antibodies fertilin beta protein in the membrane of human spermatozoa induce agglutination and reduce motility thus reducing the number of in vitro fertilization. Research conducted at the IVF Laboratory, Department of Biology of Medicine, Faculty of Medicine, University of Airlangga. This research includes: Test the potential of antibody protein beta fertilin membrane of human spermatozoa and inhibit the role of antibodies in vitro fertilization in mice (Mus musculus Balb/c). In vitro studies have resulted in fertilization figure of 25% is smaller than the number that is equal to control fertilization of 58.7%, whereas previously the spermatozoa were incubated first with a beta membrane protein antibody fertilin human spermatozoa. While the percentage of inhibition of sperm to fertilize an oocyte by 33.75%. Potential imunokontraseptif considered effective if it decreased significantly (P <0.05) than the numbers fertilization in the treatment group compared with the control group. This shows fertilin beta membrane protein antibody has the ability to inhibit human spermatozoa to fertilize oocytes that reduce the number of fertilization.
机译:作为潜在候选免疫控制材料的材料之一是精子。 Fertilin Beta是精子膜膜蛋白,仅在成熟的精子和射精中发现,用作粘附分子。用作成分免疫控制候选物的精子膜蛋白必须具有特异性标准,即精子的特异性,抗原在施肥过程中的作用,包括形成免疫原性足够的抗体反应的潜力阻断施肥。针对精子的抗体影响生殖过程施肥前的阶段,并妨碍受精后胚胎的发育。到目前为止,非常几乎没有研究数据精子膜蛋白,作为成分免疫控制达到实验动物的试验。研究目的是证明生长抗体诱导抗体诱导抗体诱导人体精子膜的抗体诱导凝集凝集,从而降低了体外施肥的次数。 Airlangga大学医学院医学系IVF实验室进行了研究。该研究包括:测试人精子的抗体蛋白β培养蛋白膜的潜力,并抑制抗体在小鼠体外施肥中的作用(Mus Musculus Balb / c)。体外研究导致施肥为25%的施肥量小于等于控制施肥的数量为58.7%,而先前将精子用β膜蛋白抗体培养胞生物体培养。虽然精子的抑制百分比将卵母细胞施肥33.75%。如果与对照组相比,潜在的imunokontrapif被认为是有效的(p <0.05)比治疗组的数量受精。这表明肥育β膜蛋白抗体具有抑制人精子的能力,以施肥减少施肥次数的卵母细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号